COMPARISON BETWEEN STANDARD TREATMENT GUIDELINES OF PREECLAMPSIA PROPOSED BY WHO AND CURRENT PRACTICE IN TERTIARY CARE CENTERS
- Publication Type:
- Journal Article
- Citation:
- WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2015, 4 (8), pp. 1566 - 1590 (24)
- Issue Date:
- 2015-07-26
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
World Health Organization introduced standard treatment guidelines for a killer disease of pregnant women worldwide, Preeclampsia, are compared with current practices in the tertiary care centers. Magnesium sulphate and delivery is the treatment of choice for pre-eclampsia. Implementation of STGs in the tertiary care centers of Islamabad that is Federal Government Services Hospital, Pakistan Institute of Medical Sciences and Shifa international Hospital are assessed. Furthermore the prescribing practice of Islamabad (three hospitals) sector is compared with such of the Abbottabad (Ayub Medical Complex), for pre-eclampsiac women. Knowledge of physicians in gynecology department at Islamabad and Abbottabad are assessed. In the tertiary care centers of Islamabad 45% patients are receiving magnesium sulphate as recommended by WHO 5% cases are delivery which is also standard way of treatment during preeclampsia. In Abbottabad sector 93% patients are receiving magnesium sulphate and 4% are delivery cases. The variation from WHO guidelines is least in Ayub Medical complex Abbottabad. This small researchon 200 patients also depicts the individual tertiary care center reports for STGs in pre-eclampsiac women. The knowledge of physician changes where a question occurs that their course of study do not contain précised WHO recognized book. There are some mind blowing facts inside this report. As a result I proudly say that our health sector is not very far away from standards proposed by World Health Organization for a better healthy environment.
Please use this identifier to cite or link to this item: